CMS Announces Cell and Gene Therapy Access Model Will Focus on Sickle Cell Disease
The model was designed to help improve health outcomes, improve access to care, and lower costs for gene therapy.
Source: pharmacytimes.com
Roberta Brodsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roberta Brodsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roberta Brodsky Today - Breaking & Trending Today
FDA Approves Breakthrough Sickle Cell Treatments
By Genoa Barrow | OBSERVER Senior Staff Writer - The FDA has approved the first two gene therapies to treat sickle cell disease, providing hope for patients, their families, and the entire sickle cell community, but the treatments are expensive and require specialized care to be effective.
Source: sacobserver.com
ASH President Speaks on Pharmacists, Novel Innovations in Hematology
He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.
Source: pharmacytimes.com
FDA Approves bluebird bio's Lovo-Cel Gene Therapy for Sickle Cell Disease
The decision was supported by efficacy data from 36 patients from the ongoing phase 1/2 HGB-206 trial (NCT02140554) and 2 patients in the phase 3 HGB-210 trial (NCT04293185). It was the second approval from FDA for a gene therapy for sickle cell disease.
Source: ajmc.com
2023 President of the American Society of Hematology Discusses Sickle Cell Disease Treatments for the 65th ASH Annual Meeting
The president highlights a new curative treatment option for sickle cell disease while also expanding on the changing treatment landscape for hematologic conditions.
Source: pharmacytimes.com